Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center



  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent


    Join Us

    News: chromatin

    Throwing a Wrench in DNA Machinery

    Thursday, December 9th, 2010

    Proteins called HDACs are the targets of a new class of anti-cancer compounds (HDAC inhibitors). How these compounds kill tumor cells — and the potential side effects of such drugs — are still open questions. Scott Hiebert, Ph.D., and colleagues at Vanderbilt-Ingram Cancer Center have now discovered that mice missing a particular HDAC (pronounced h-dack) […]